Juan C Jimenez

"Digital health is no longer the future; it is the present, reshaping our healthcare landscape in real-time." Excited to be part of the UCSF Digital Health Hub Foundation's Quarterfinalist Party! As a past board member, I'm honored to celebrate the outstanding quarterfinalists. As we reflect on the state of digital health in 2024, it's evident that the COVID-19 pandemic has fundamentally transformed healthcare delivery. The rapid adoption of telemedicine during the crisis has become a permanent fixture, with over 60% of physicians continuing to utilize this technology. The sprint towards smarter healthcare, catalyzed by necessity, has shattered preconceptions about digital-first health experiences. Virtual care is no longer a stopgap but an integral part of a seamless, anytime, anywhere health ecosystem. 🌍 We're witnessing the rise of B2B2C models in remote consultations, with companies like Teladoc Health and Amwell partnering with insurance providers to integrate their services into health plans. Public sector collaborations, like eConsult Health 's partnership with the NHS in the #UK, underscore the potential for remote consultations to enhance efficiency and accessibility at a national level. The digital health landscape is evolving rapidly, with advancements in remote consultations, mental health support, at-home diagnostics, and patient monitoring. AI and generative AI transform care delivery, making it more efficient, personalized, and patient-centric. 🤖 Yet, challenges remain. While venture capital funding for digital health has stabilized after the pandemic boom, it remains below its 2021 peak. Sectors like digital therapeutics face reimbursement hurdles, and we've seen major players like Walmart and Optum close telehealth businesses. Looking ahead, we anticipate further consolidation in digital health, driven by acquisitions to create broader ecosystems encompass telemedicine, mental health, and other specialized services. As healthcare leaders, we must leverage these digital advancements to improve access, enhance patient outcomes, and drive efficiency in our healthcare systems. The future of healthcare is digital, and the time to embrace this transformation is now. Congratulations to all the finalists! 🎉 Looking forward to the grand finale at #HLTH2024 in #LasVegas! 🙌 By the way, the pink drink that we were holding was delicious—and nonalcoholic! The Digital Health Hub Foundation - Digital Health Awards #HealthcareInnovation #DigitalHealth #UCSFHealthHub #Networking #HealthTech #Entrepreneurship #LasVegasFinale Walter Greenleaf, PhD Daniel Kraft, MD Unity Stoakes StartUp Health University of California, San Francisco UCSF Innovation Ventures American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society #AAPMhealth #aapm_health

94

7 Comments

🔔 In today's HealthTech of the Week series, I'm presenting something special. Instead of showing you another exciting startup, I will share an insightful interview with Olivia BLANCHARD, Managing Director at Health Venture Lab (HVL), an international accelerator supported by GE HealthCare. 🔥🔥 🔍 Discover how HVL is empowering startups to redefine healthcare through innovation and technology. Highlights from our conversation include: 🔹HVL’s role in accelerating medical innovations without equity participation. 🔹Benefits for startups include access to a robust international network and strategic development opportunities. 💡 Dive into the full interview to see how HVL is shaping the future of healthcare! The article is available in two language versions. 👉 EN: https://lnkd.in/dvvThsBA 👉 PL: https://lnkd.in/dfGTfyuF Olivia BLANCHARD, Thank you very much for sharing your amazing experience with us! 💙 PS. If you are interested in the HealthTech of the Week series, you can find more interesting materials on my blog! #HealthTech #Innovation #HealthVentureLab #HealthTechOfTheWeek #MedTech #HVL

13

2 Comments

I’m optimistic about the potential of generative AI to reduce provider burnout and improve provider-patient interactions. However, that optimism is tempered by the data that indicates the technology is not quite ready yet. Bright Ventures is interested in digital health founders who understand the realities of provider-patient interactions, and the role technology can play in strengthening clinical outcomes. Which founders and teams are getting this right? Tag them in the comments below.

50

2 Comments

🚀 Meet Our Advisors! We are excited to highlight that Bill Reichert, General Partner of Pegasus Tech Ventures, as one of the esteemed advisors in our #H7 accelerator program. 👉 Don't miss out on the opportunity to be part of H7 BioCapital's global healthcare accelerator. Apply now for the #H7 Accelerator Program Online. Early Bird Applications are open until 💥 July 20th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 20th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Bill Reichert! "Bill Reichert is a #veteran #entrepreneur, having been a founder at five startups, two of which went public, and he is a seasoned venture capital investor, with over 200 investments, several in unicorns, and several in #healthtech #startups." 🌷Apply now to learn invaluable insights from Bill Reichert and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #entrepreneur #clinicaltrials #oncology #research #startup #founders

25

1 Comment

Are digital health startups in a quiet struggle? They raised $5.7 billion in the first half of 2024, signaling a potential rebound. With AI driving investments, this year's totals might surpass last year's and challenge 2019's $8.2 billion record. This funding is crucial for driving healthcare innovations. Yet, startups struggle to deliver returns, with acquisitions dropping from 278 in 2021 to just 66 this year. Many startups face hurdles in gaining the momentum needed for liquid dollars, IPOs, and acquisitions. The healthcare market is difficult to crack, and there’s often a mismatch in valuations. One challenge on the customer end for virtual-care companies: consumers often can switch easily from one to the next (Charlotte Ross) Also - "AI-enabled" is constantly being pitched, and often missing a competitive advantage, like a proprietary data set. Everyone is calling themselves AI-first, and the traditional VC playbook doesn't apply to AI (most large incumbents have an AI strategy). Thoughts? #DigitalHealth #VentureCapital #AI https://lnkd.in/eHbhJNwF

7

Today's post is about our commitment at Bread and Butter Ventures to investing in women's health within our healthcare vertical, which is a big focus of our fund. Our mission in healthtech broadly is to invest in technology that democratizes access to quality care for all. A report this year from Deloitte shared that investment in women’s health rose by 5% between 2022 and 2023 - heading in the right direction, however, women's health represented just 2% of the $41.2 billion in venture funding that went to health companies in 2023, according to Deloitte’s analysis. There is such tremendous opportunity to innovate and invest for half the world's population. This an economic imperative. Spotlighting today 5 outstanding healthcare startups innovation in women's health who are very proud to have in our portfolio: ⭐ Gabbi: is building a comprehensive breast cancer risk assessment and early detection platform, combining cutting-edge technology with personalized care. As a woman's virtual breast specialist, Gabbi ensures every woman knows her risk and has access to early detection via telehealth. https://www.gabbi.com/. Shoutout Kaitlin Christine ⭐ Chiyo: is a personalized & integrative food-as-medicine platform that helps the next generation of mothers looking for guidance as they navigate the acute transitions of fertility, pregnancy and post-partum. https://wearechiyo.com/. Shoutout Irene Liu ⭐ Delfina: is creating an AI-powered pregnancy care platform to solve the global maternal health crisis. Delfina lowers rates of adverse outcomes, hospitalizations, and NICU stays to deliver substantial savings for health plans and risk-sharing providers. https://www.delfina.com/. Shoutout Senan Ebrahim, MD, PhD Priyanka Vaidya Ali Ebrahim ⭐ Nest Collaborative is the first to create a nationwide network of lactation consultants, available to mom 24/7 through virtual consultations. We were also the first to offer mom a no-cost, insurance-paid experience - which means when she has a problem we can connect her with a consultant within hours and we take care of all the payment and paperwork on the back end. We are, in all ways, her BFF - Breast Feeding Friend. https://lnkd.in/gKCVYvtF. Shoutout Judith Nowlin ⭐ Myya: provides breast cancer survivors completely customizable, fully insurance billable post-mastectomy prosthetics with a state-of-the-art fitting experience online and in-person. https://myya.com/ Jasmine Jones #womenshealth #digitalhealth #venturecapital #startups

91

4 Comments

As physicians, we are committed to improving patient care through clinical excellence. However, there's an often-overlooked avenue where our expertise can significantly impact healthcare innovation: serving as medical advisors for startups. Here are a few reasons why I believe we should engage with the entrepreneurial community 👇 1️⃣ Driving Innovation Forward: Startups are at the forefront of medical technology and services. By contributing our clinical expertise, we can guide these companies to develop solutions that are not only innovative but also practical and patient-centered. 2️⃣ Broadening Impact: While our primary influence is within the confines of our practices or hospitals, working with startups allows us to extend our impact globally. Technologies we help develop could benefit patients worldwide, many of whom could never visit us in person. 3️⃣ Learning and Growth: Engaging with startups exposes us to the latest technologies and business strategies, enriching our understanding beyond the medical field. This cross-disciplinary knowledge can enhance our own practices and the way we approach patient care. 4️⃣ Professional Networking: Collaborating with entrepreneurs and other tech innovators can open new doors. These connections can lead to other advisory roles, speaking opportunities, and even advancements in our own careers. 5️⃣ Financial Opportunities: Often, advising roles come with financial compensation, including equity options. These can provide significant financial benefits, particularly if the startup succeeds. 6️⃣ I urge my fellow clinicians to consider stepping into the role of a medical advisor. Our insights are invaluable, and our participation can be the key differentiator in the success of health-focused innovations. ---- Join our vibrant community of 2,000+ healthtech experts and thought leaders. Comment below or DM me, and I’ll provide you with an invitation to our fast-growing network. 📩

50

9 Comments

🌟 Capital for Cures: A New Platform for Healthcare Transformation 🌟 At the beginning of this year, Capital for Cures launched with a bold vision: to mobilize more capital for emerging healthcare companies and solutions. The mission is simple yet urgent—funding healthcare innovation shouldn’t rely solely on the pharmaceutical industry. By expanding our partner network, engaging with pension funds, insurance companies, and other investors, and securing foundational capital, we aim to cultivate the next wave of angel investors, foster collaboration, and provide innovators with the capital they need to thrive. How It Started The idea for Capital for Cures arose from a clear gap in the industry. Early-stage healthcare companies often struggle to secure critical funding, while traditional industry events fail to provide the intimate, action-driven forums needed for impactful collaboration. This inspired the creation of a platform dedicated to fostering meaningful connections among innovators, investors, and policymakers. Recent Milestones Earlier this month, our AI Roundtable in Basel brought together senior leaders from Swiss companies and big data providers involved in foundational AI models, highlighting the urgent need for companies to engage directly with regulators to shape practical AI policies. Additionally, the Capital for Cures event in Frankfurt reinforced the demand for forums like ours. Unlike large-scale conferences, these events showcased the power of action-oriented collaboration to unlock new opportunities. Our Vision for the Future We’re building a fully-fledged platform for transformation: Engaging New Investors: Attracting non-traditional investors, like pension funds and insurance companies, to unlock significant healthcare funding potential. Cultivating Angel Investors: Encouraging successful founders to reinvest in the ecosystem, fueling continuous innovation. Fostering Meaningful Connections: Bridging the gaps left by traditional conferences like Bio-Europe and JP Morgan. Next Steps We are raising $300k USD to scale our vision and mobilize more capital for healthcare innovation. Expanding our partner network is critical to supporting emerging companies and driving impactful change. Join Us Contribute to Our Advisory Board: Bring your expertise or recommend key leaders. Partner with Us: Offer financial or non-monetary support to help scale this transformative initiative. Participate in Upcoming Events: Join our next roundtable to shape the future of AI and healthcare. Together, we can build a brighter future for healthcare by empowering innovators, mobilizing investors, and influencing policies for meaningful change.

19

1 Comment

Check out how AccurKardia is taking what Cardiologs started to a whole new level in Artifical Intwlligence of ECGs! American Heart Association MedTech Innovator Heart Rhythm Society LSI #epeeps European Society of Cardiology

11

APPLICATIONS ARE OPEN for Healthworx Accelerator! Are you a healthcare entrepreneur of a pre-seed or seed stage company who wants to connect with payers and providers like CareFirst BlueCross BlueShield to further hone your product and business? Do you want to learn about all the best practices in procurement, data security, claims, contracting, and the other nitty gritty details that might make or break your business? This is the iteration of 1501 Health, and includes all of our best practices and lessons learned to support even more entrepreneurs! If you have questions, please reach out to Soo Jeon or any of our alumni who can share the transformation that's possible when you connect innovators with experts!

46

2 Comments

🚀 This Healthtech Startup Raises $600 Million in Series D Funding Round, at a Valuation of $3 Billion 🚀 CMR Surgical, the pioneering company behind the Versius surgical robotic system, has achieved a significant milestone, solidifying its position as a global leader in robotic surgery technology. 🤝 Success Highlights: 1️⃣ CMR Surgical's Versius system has been widely acclaimed for its precision, versatility, and potential to revolutionize minimally invasive surgery. 2️⃣ Strategic partnerships with leading healthcare institutions and key opinion leaders, enhancing the adoption and advancement of robotic-assisted surgery worldwide. 3️⃣ Expansion into new markets and ongoing innovation, driving the transformation of surgical care and improving patient outcomes. 👉🏻 Key Highlights: 1️⃣ Surpassing the $1 billion valuation mark, CMR Surgical reaffirms its status as a frontrunner in the surgical robotics industry. 2️⃣ Series D funding totalling an impressive $600 million, led by prominent investors including SoftBank Vision Fund and Ally Bridge Group. 3️⃣ Continued advancement of the Versius platform, expanding its applications and accessibility across diverse surgical specialities. Let's Dive into CMR Surgical's Phenomenon: 🔷 Culture of Innovation: Behind CMR Surgical's groundbreaking success lies a culture deeply rooted in innovation. Martin Frost and the visionary team at CMR Surgical embody the spirit of relentless innovation, driving the evolution of surgical robotics and transforming patient care. 🔷 Industry Leadership: CMR Surgical's ability to secure $600 million in Series D funding underscores its leadership in the surgical robotics landscape. The confidence shown by investors highlights CMR Surgical's unmatched potential to redefine the future of surgery. 🔷 Setting the Benchmark: From its inception in 2014 to its current position as an industry disruptor, CMR Surgical's journey epitomizes the art of strategic fundraising. The ability to attract substantial investments reflects CMR Surgical's compelling vision and transformative impact on healthcare. 🔷 Identity and Impact: CMR Surgical's identity is synonymous with innovation and impact. Its commitment to advancing surgical robotics technology and improving patient outcomes reflects its dedication to pushing the boundaries of medical innovation. 💬 Point of Thought: "CMR Surgical's rise to a heightened valuation sparks intriguing questions in a healthcare landscape. What sets it apart in the realm of surgical robotics? And what new frontiers will it explore next?" Let's continue to push the boundaries of medical technology and shape the future of surgical care together! 💪 ➕ Follow Shilpi Kumari for more insightful updates. #surgicalrobotics #healthcaretechnology #medicalinnovation #fundraising #venturecapital #linkedin

31

6 Comments

Awesome report from Rock Health (in the comments) about H124 digital health funding. 📈 Despite broader economic challenges, the digital health sector, including mental health, has shown resilience, raising $5.7B across 266 deals. There is a strong Series A pipeline, tapering off of unlabeled funding rounds and 3 public exits in Q2 2024 indicating a revival in the exit market and a return to more sustainable funding patterns​. Key insights about the mental health market: 🧠 Mental health continues to be the leading clinical indication in digital health funding, securing $682 million in H1 2024. This consistent top ranking highlights the ongoing investor interest and the market's recognition of the critical need for mental health solutions. 🤖 The focus on mental health is driven by a combination of increased awareness, the rising demand for accessible mental health services, and the integration of tech solutions...🙄 In fact, AI has become a significant factor in digital health investments, with 34% of the total sector funding going to AI-startups. This trend is also reflected in mental health, where AI is being utilised to enhance diagnosis, personalise treatment plans, and provide scalable, efficient care solutions. Let's go!

22

1 Comment

🚀 Meet Our Advisors! We are excited to highlight that Neil Littman, Founding Partner of Bioverge Ventures and Partner of Riverine Ventures, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 20th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 20th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Neil Littman "Neil Littman, M.S. is Founder & CEO of Bioverge Ventures, a venture capital firm exclusively dedicated to investing in #earlystage, #cuttingedge #healthcare companies. Bioverge’s investment thesis is focused on companies spanning the intersection of health + tech that are utilizing advances in technology to modernize healthcare, from bench-to-bedside." "Previously, Neil was Vice President of Business Development at Notable Labs, an oncology startup and Bioverge portfolio company, where he led the development of global corporate partnerships and contributed to the strategic vision of Notable as part of the Senior Leadership Team. Neil oversaw business development at Notable through the successful completion of the company’s $40 million Series B and was instrumental in negotiating multiple terms sheets to in-license clinical stage oncology assets." 🌷Apply now to learn invaluable insights from Neil Littman get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales

33

3 Comments

When I developed my investment thesis as part of my venture fellowship with Material Change Institute, I knew that it would be healthcare focused. One of the key areas is food as medicine. For too long we have lived as a society of sick care vs proactive healthcare. The incentives need to change in what insurers pay for. Proactive healthcare is not 'experimental'. The amount of processed food that Americans eat needs to change and that starts with the big food manufacturers. Excellent topics for another time! Good healthcare comes in so many forms -- physical, mental, social, emotional, environmental -- and it is important to focus all of them. A few years ago I become very interested in the emerging area of food as medicine from my own personal journey. Despite being what I thought was healthy eating, there was so much more that I had to learn. 💡 Here are a few lessons I've learned -- 👩‍🌾 The source of our food matters. Good soil and regenerative farming are key. 🍩 Sugar is bad -- which I knew -- but there are better ways to satisfy your sweet tooth. 👩‍⚕️ Gut health and inflammation are critical to our overall health. Understand your level of internal inflammation, what's contributing to it, and reset your microbiome. Inflammation is the starting point of so many diseases. There is so much more to understand in this emerging field. WittKieffer put together a comprehensive graphic that outlines the depth of this space. It's the best representation of it that I've seen. Thank you Ysette Witteveen for sharing this! As the holidays approach and you may be looking for great documentaries to watch, I suggest Netflix's Kiss the Ground, Common Ground and You are What You Eat. #foodasmedicine #longevity #activeaging #proactivehealthcare #nutrition #investing

6

In this episode of The Lobster Talks, Daniel Kivatinos of JustPaid.io reveals the inspiration behind DrChrono, his first venture that led to a top 1% YC exit. Witness the pivotal moment when he identified a pressing need in the healthcare industry and embarked on a journey to revolutionize it through technology. Key takeaways from this episode: -Identifying Pain Points: How Daniel recognized the inefficiencies in the healthcare system and envisioned a digital solution. -The Birth of DrChrono: The story behind the company's founding and its initial focus on patient appointment reminders. -Iterative Development: How Daniel and his co-founder embraced feedback and continuously improved their product. -The Power of Passion: Why working on something you believe in is crucial for entrepreneurial success. Tune in to the full episode to learn how Daniel's passion and dedication transformed a simple idea into a groundbreaking healthcare platform. Watch on YouTube Here - https://lnkd.in/ev8B-JFJ . . . . . #FinTech #Healthcare #Startups #Entrepreneurship #LobsterTalks

3

Interesting report from PitchBook on first quarter Digital Health VC activity. - $1.1 billion in funding. Key late-stage deals were led by Transcarent ($126M) and Rightway ($108.8M). - The top investment categories were general & primary care ($213.4M) and health benefits navigation ($140.7M). Challenges & Trends: Valuations: Less than 20% of startups reported a priced round in the last 18 months, with an increase in extension/bridge rounds. Digital Therapeutics: Facing significant challenges due to elusive reimbursement and cautious investors. Better Therapeutics is winding down operations, and Akili is being taken private for $34M, a sharp decline from its peak valuation of nearly $450M. Telehealth: Setbacks include the shutdown of Optum's virtual care and Walmart's telehealth services. The pandemic saw over $15B in VC funding since 2020, but some platforms struggled with unsustainable business models and strategic missteps (e.g., Teladoc's costly Livongo acquisition and Amwell's delisting from Nasdaq). Looking Ahead: While digital therapeutics and telehealth face hurdles, there's potential in: Platforms integrating various treatments for conditions like diabetes, metabolic health, and mental health. Specialty telemedicine, B2B platforms, and hybrid-care models, which offer a promising investment outlook. Despite current challenges, strategic investments and a focus on sustainable models can drive the next wave of innovation in digital health. As a former digital health founder, I encourage founders in this space to keep going...there is light at the end of the tunnel! If you are a digital health founder with impressive traction based in Virginia, feel free to reach out! #digitalhealth #venturecapital #virginiaipc #virginiainvests

28

2 Comments

🔥 For Mothers and Children – 10 Startups Revolutionizing Healthcare! 🔥 As part of the HealthTech of the Week series, I'm excited to share the latest article highlighting 10 groundbreaking startups from the Mother and Child Startup Challenge. These companies are creating innovative solutions that aim to transform healthcare for mothers and children, addressing challenges in diagnostics, treatment, and hospital management. From real-time sepsis analyzers to AI-powered ovarian cancer diagnostics, these innovations are shaping the future of medical care in ways we couldn’t imagine just a few years ago. 🚀 In this article, you'll discover cutting-edge ideas that are not only improving health outcomes but also redefining how medical services are delivered. Whether you're interested in medical technology, healthcare innovations, or simply the future of care for women and children, this article is for you!👩‍⚕️👶 The article is available in two language versions. 👉 EN: https://lnkd.in/dyCYgAbS 👉 PL: https://lnkd.in/dYJYfRTi As Come Creations Group, we are proud to be partners of the Mother and Child Startup Challenge. 💪 📖 Read the full article to find out more about these inspiring startups and their solutions #MotherAndChildStartupChallenge #Innovation #HealthTech #MedTech #StartupEvent #Partnership

16

4 Comments

As we look for ways to control healthcare costs globally without compromising accessibility to, or quality of patient care, (tech-enabled) outcome-based contracting is the only solution.

14

Thank you FII8 for the distinguished opportunity to moderate the panel on "How can health startups access more data to scale?" It is an honor to address such an esteemed gathering of visionaries and leaders. AI's integration into healthcare startups is pivotal, with a strong emphasis on ensuring data quality and optimizing AI-enhanced workflows. To maintain high-quality outputs and prevent data leaks, robust governance and stringent data protection measures are essential. Personalized medicine, which heavily relies on diverse datasets, underscores the critical importance of varied research samples. The rapid advancements within this field highlight the necessity for accessible tools that empower researchers and innovators. As we navigate this transformative era, fostering collaboration and sharing insights are paramount to driving sustainable growth and innovation in healthcare. #FII #FutureInvestmentInitiative #FII8 #Healthcare #Innovation #Investment #Industry #Business #Startup #AI #Medtech #Data #Medicine #Personalized #Advancement #Collaboration #Growth

78

2 Comments